Literature DB >> 12711287

Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy.

M P Schijven1, A J J M Vingerhoets, H J T Rutten, G A P Nieuwenhuijzen, R M H Roumen, M E van Bussel, A C Voogd.   

Abstract

AIMS: The use of axillary lymph node dissection (ALND) in women with breast cancer is associated with considerable morbidity. Sentinel node biopsy (SNB) removes the lymph node in the axillary basin indicative for receiving first lymphatic drainage from the breast. This study compares the nature and severity of physical morbidity among breast cancer patients who underwent primary surgery for breast cancer combined with either ALND or SNB. Also, it assesses influence of subsequent radiotherapy on morbidity.
METHOD: Two hundred and thirteen ALND patients were compared with 180 SNB patients retrospectively. Morbidity was measured using a disease-specific quality-of-life questionnaire.
RESULTS: Patients' demographic characteristics were alike. The axillary procedure is the strongest and most consistent factor in explaining differences in a variety of self-reported complaints. Patients having had SNB have a 3.2-fold lower risk of experiencing pain, a 5-fold lower risk of lymph oedema, a 7.7-fold lower risk of numbness, a 3.7-fold lower risk of tingling sensations, a 7.1-fold lower risk of loss of strength in arm/hand, a 3.6-fold lower risk of loss of active motion range of the arm and a 2.9-fold lower risk of impaired use of the arm. Axillary radiation therapy adds to complaints next to the axillary surgical procedure by increasing the risk of lymph oedema 2.4-fold and enhancing the risk of impaired use of the arm by 2.6-fold. Axillary radiation therapy does not explain lymph oedema by itself.
CONCLUSION: SNB is associated with less morbidity compared to ALND in patients with primary breast cancer.

Entities:  

Mesh:

Year:  2003        PMID: 12711287     DOI: 10.1053/ejso.2002.1385

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  43 in total

1.  Risk factors for lymphedema after breast cancer treatment.

Authors:  Sandra A Norman; A Russell Localio; Michael J Kallan; Anita L Weber; Heather A Simoes Torpey; Sheryl L Potashnik; Linda T Miller; Kevin R Fox; Angela DeMichele; Lawrence J Solin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-10-26       Impact factor: 4.254

2.  Survival analysis following sentinel lymph node biopsy: a validation trial demonstrating its accuracy in staging early breast cancer.

Authors:  John T Carlo; Michael D Grant; Sally M Knox; Ronald C Jones; Cody S Hamilton; Sheryl A Livingston; Joseph A Kuhn
Journal:  Proc (Bayl Univ Med Cent)       Date:  2005-04

3.  Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: National Surgical Adjuvant Breast and Bowel Project phase III protocol B-32.

Authors:  Stephanie R Land; Jacek A Kopec; Thomas B Julian; Ann M Brown; Stewart J Anderson; David N Krag; Nicholas J Christian; Joseph P Costantino; Norman Wolmark; Patricia A Ganz
Journal:  J Clin Oncol       Date:  2010-08-02       Impact factor: 44.544

4.  Risk of decline in upper-body function and symptoms among older breast cancer patients.

Authors:  Jennifer L Westrup; Timothy L Lash; Soe Soe Thwin; Rebecca A Silliman
Journal:  J Gen Intern Med       Date:  2006-04       Impact factor: 5.128

Review 5.  Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations.

Authors:  Balazs I Bodai; Phillip Tuso
Journal:  Perm J       Date:  2015

6.  Prediction of involvement of sentinel and nonsentinel lymph nodes in a Canadian population with breast cancer.

Authors:  Ravi Ramjeesingh; May Lynn Quan; Sandra Gardner; Claire M B Holloway
Journal:  Can J Surg       Date:  2009-02       Impact factor: 2.089

7.  The effect of simulation on recurrence after breast-conserving surgery and radiotherapy: preliminary results.

Authors:  Ji-Yoon Kim; Yeon-Sil Kim; Mi-Ryung Ryu; Sung-Whan Kim; Chul-Seung Kay; Sei-Chul Yoon; Woo-Chan Park; Byung-Joo Song; Se-Jeong Oh; Sang-Seol Jung; Jong-Man Won; Seung-Nam Kim; Su-Mi Chung
Journal:  Cancer Res Treat       Date:  2006-02-28       Impact factor: 4.679

Review 8.  Sentinel lymph node biopsy progress in surgical treatment of cancer.

Authors:  T Schulze; A Bembenek; P M Schlag
Journal:  Langenbecks Arch Surg       Date:  2004-06-09       Impact factor: 3.445

9.  Five-year follow-up of treatment outcomes in patients with early-stage breast cancer and clinically negative axillary nodes treated with no lymph node dissection or axillary clearance.

Authors:  Daigo Yamamoto; Kanji Tanaka; Yu Tsubota; Noriko Sueoka; Tetsuji Shoji; Kayoko Kuwana; A-Hon Kwon
Journal:  Breast Cancer (Dove Med Press)       Date:  2012-08-27

10.  Quality of life after axillary or groin sentinel lymph node biopsy, with or without completion lymph node dissection, in patients with cutaneous melanoma.

Authors:  Mattijs de Vries; Harald J Hoekstra; Josette E H M Hoekstra-Weebers
Journal:  Ann Surg Oncol       Date:  2009-07-29       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.